Compare PROF & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | USAU |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Canada | United States |
| Employees | N/A | 4 |
| Industry | Medical/Dental Instruments | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.8M | 214.2M |
| IPO Year | 2017 | 2020 |
| Metric | PROF | USAU |
|---|---|---|
| Price | $7.44 | $12.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $12.00 | ★ $22.83 |
| AVG Volume (30 Days) | 118.2K | ★ 222.2K |
| Earning Date | 05-07-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.89 | ★ 36.11 |
| EPS | ★ 0.19 | N/A |
| Revenue | $16,098,000.00 | ★ $17,402,000.00 |
| Revenue This Year | $92.40 | N/A |
| Revenue Next Year | $64.10 | N/A |
| P/E Ratio | $38.32 | ★ N/A |
| Revenue Growth | ★ 50.73 | N/A |
| 52 Week Low | $3.92 | $10.32 |
| 52 Week High | $8.95 | $23.72 |
| Indicator | PROF | USAU |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 37.56 |
| Support Level | $7.00 | N/A |
| Resistance Level | $7.93 | $16.50 |
| Average True Range (ATR) | 0.38 | 0.70 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 40.26 | 23.92 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
U.S. Gold Corp is a gold, copper and precious metals development and exploration company pursuing exploration opportunities mainly in Wyoming, Nevada and Idaho. It is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada and the Challis Gold Project in Idaho. The company is engaged in the exploration and evaluation of its mineral properties, which is the single operating segment.